0001127602-20-021918.txt : 20200721 0001127602-20-021918.hdr.sgml : 20200721 20200721204339 ACCESSION NUMBER: 0001127602-20-021918 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200720 FILED AS OF DATE: 20200721 DATE AS OF CHANGE: 20200721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zaks Tal Zvi CENTRAL INDEX KEY: 0001690927 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 201040048 MAIL ADDRESS: STREET 1: 122 BELLEVUE STREET CITY: NEWTON STATE: MA ZIP: 02458 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-07-20 0001682852 Moderna, Inc. MRNA 0001690927 Zaks Tal Zvi C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Chief Medical Officer Common Stock 2020-07-20 4 M 0 10000 20.93 A 10000 D Common Stock 2020-07-20 4 M 0 10000 19.15 A 20000 D Common Stock 2020-07-20 4 S 0 400 78.77 D 19600 D Common Stock 2020-07-20 4 S 0 1650 80.49 D 17950 D Common Stock 2020-07-20 4 S 0 2205 81.23 D 15745 D Common Stock 2020-07-20 4 S 0 4488 82.49 D 11257 D Common Stock 2020-07-20 4 S 0 3425 83.17 D 7832 D Common Stock 2020-07-20 4 S 0 2409 84.53 D 5423 D Common Stock 2020-07-20 4 S 0 3469 85.58 D 1954 D Common Stock 2020-07-20 4 S 0 1000 86.37 D 954 D Common Stock 2020-07-20 4 S 0 354 87.41 D 600 D Common Stock 2020-07-20 4 S 0 400 88.76 D 200 D Common Stock 2020-07-20 4 S 0 200 90.64 D 0 D Stock Option (Right to Buy) 20.93 2020-07-20 4 M 0 10000 0 D 2020-03-08 2029-03-08 Common Stock 10000 309195 D Stock Option (Right to Buy) 19.15 2020-07-20 4 M 0 10000 0 D 2026-08-10 Common Stock 10000 214790 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.41 to $79.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.77 to $80.76 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.80 to $81.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.81 to $82.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.82 to $83.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.96 to $84.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $84.97 to $85.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.98 to $86.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.05 to $87.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.59 to $88.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. This option is fully vested and exercisable. This option is fully vested and exercisable. /s/ Lori Henderson, as Attorney-in-Fact 2020-07-21